Search This Blog

Wednesday, March 6, 2019

Assertio Therapeutics reports Q4 EPS 30c, consensus 20c

Reports Q4 revenue $62.8M, consensus $60.91M.
https://thefly.com/landingPageNews.php?id=2875411

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.